As in Eμ-TCL1 mice, AID−/−/Eμ-TCL1 mice accumulated a population of CD19+/B220low/CD5+ CLL cells in the spleens during leukemic progression, eventually making up a majority of the splenocytes (Fig. S2A). This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.